Avadel Pharmaceuticals plc (AVDL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 999.93M |
| Enterprise Value | 950.26M |
| P/E Ratio | -7,558.74 |
| PEG Ratio | -11.49 |
| Price/Sales Ratio | 8.55 |
| Price/Book Ratio | 21.39 |
| Enterprise/Revenue | 8.38 |
| Enterprise/EBITDA | 205.48 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -0 |
| Operating Margin | 0.02 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 169.12M |
| Revenue/Share | 2.56 |
| Gross Profit | 153.84M |
| EBITDA | -35.57M |
| Net Income | -48.83M |
| Diluted EPS | -0.51 |
| Total Cash | 91.58M |
| Total Cash/Share | 0.94 |
| Total Debt | 37.38M |
| Total Debt/Equity | 0.38 |
| Current Ratio | 2.76 |
| Book Value Per Share | 1.01 |
| 52-Week Change | 144.8 |
| 52-Week High | 23.57 |
| 52-Week Low | 6.38 |
| Moving Average 50 Days | 21.5 |
| Moving Average 200 Days | 15.49 |
| Average Volume | 2.42M |
| Shares Outstanding | 98.15M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |